Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival".
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.
Glaser AW, Corner JL. Are you the author?
Leeds Teaching Hospitals NHS Trust, Leeds Institute of Cancer and Pathology, Leeds, UK; Faculty of Health Sciences, Southampton University, Southampton, UK; Macmillan Cancer Support, London, UK.
Reference: Eur Urol. 2014 Nov 10. pii: S0302-2838(14)01037-9.